Vanda Pharmaceuticals (VNDA) stock price, revenue, and financials

Vanda Pharmaceuticals market cap is $722.4 m, and annual revenue was $193.12 m in FY 2018

$722.4 M

VNDA Mkt cap, 10-Jun-2019

$47.7 M

Vanda Pharmaceuticals Revenue Q1, 2019
Vanda Pharmaceuticals Net income (Q1, 2019)-612 K
Vanda Pharmaceuticals EBIT (Q1, 2019)-2.1 M
Vanda Pharmaceuticals Cash, 31-Mar-201934.4 M

Vanda Pharmaceuticals Income Statement

Annual

USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

33.9m109.9m146.0m165.1m193.1m

Cost of goods sold

23.5m

Gross profit

86.5m

Gross profit Margin, %

79%

R&D expense

28.2m29.1m29.2m38.5m43.6m

General and administrative expense

24.6m84.5m99.8m123.8m105.8m

Operating expense total

54.3m150.1m164.6m182.0m171.4m

EBIT

(20.4m)(40.2m)(18.6m)(16.9m)21.7m

EBIT margin, %

(60%)(37%)(13%)(10%)11%

Pre tax profit

(17.9m)(15.4m)25.3m

Income tax expense

104.0k136.0k138.0k

Net Income

(20.3m)(39.9m)(18.0m)(15.6m)25.2m

Vanda Pharmaceuticals Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

64.8m60.9m50.8m40.4m33.6m61.0m

Accounts Receivable

2.0m3.7m16.3m20.3m17.6m28.8m

Inventories

2.7m3.1m1.3m779.0k840.0k994.0k

Current Assets

135.6m141.7m166.5m174.2m169.9m299.1m

PP&E

2.2m2.4m4.6m5.0m5.3m4.4m

Total Assets

143.3m171.7m213.1m210.4m205.4m332.1m

Accounts Payable

661.0k835.0k15.8m16.2m20.3m21.6m

Short-term debt

Current Liabilities

32.9m7.8m51.3m50.3m70.4m53.0m

Long-term debt

Total Debt

Total Liabilities

99.2m80.0m79.0m74.0m56.7m

Additional Paid-in Capital

355.4m448.7m460.8m477.1m492.8m611.6m

Retained Earnings

(311.4m)(288.0m)(327.8m)(345.9m)(361.4m)(336.2m)

Total Equity

44.1m160.8m133.0m131.3m131.4m275.4m

Financial Leverage

3.2 x1.1 x1.6 x1.6 x1.6 x1.2 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Cash

142.2m43.3m17.0m15.3m32.8m48.3m46.8m38.7m23.2m32.8m20.1m14.2m22.6m155.3m60.9m60.8m34.4m

Accounts Receivable

2.0m1.7m2.4m3.7m20.1m15.8m15.8m16.7m14.0m15.9m17.8m21.0m18.2m23.3m24.9m25.3m26.3m

Inventories

192.0k1.1m1.3m5.2m5.0m3.8m938.0k927.0k865.0k816.0k742.0k921.0k1.0m1.2m887.0k1.1m

Current Assets

147.1m105.5m71.2m64.8m162.2m174.4m173.9m162.4m160.4m170.4m168.6m174.6m169.7m282.4m269.1m278.8m306.5m

PP&E

2.1m2.2m2.3m2.2m3.1m3.9m4.2m4.4m4.2m4.7m5.5m5.7m5.4m5.1m4.8m4.6m4.3m

Total Assets

155.1m121.0m86.2m79.2m213.6m223.7m220.5m206.7m202.0m208.4m204.7m210.7m205.7m317.3m302.9m311.9m351.2m

Accounts Payable

369.0k953.0k248.0k547.0k1.5m1.6m45.9m22.7m17.9m17.6m18.0m19.1m18.9m17.2m18.6m19.0m27.4m

Current Liabilities

31.9m45.4m38.3m38.8m31.8m45.2m45.9m55.0m51.8m50.7m73.0m75.4m71.5m72.0m46.9m46.2m59.3m

Total Liabilities

105.1m100.0m85.3m78.1m73.9m74.6m83.7m80.4m79.3m76.6m79.3m75.2m76.2m51.7m50.5m72.8m

Additional Paid-in Capital

353.7m355.6m357.1m358.7m450.6m453.3m458.9m463.1m466.3m474.2m481.6m486.4m489.9m604.9m607.9m615.0m

Retained Earnings

(303.7m)(334.7m)(356.3m)(357.7m)(298.2m)(303.6m)(313.1m)(340.2m)(344.8m)(345.3m)(353.5m)(355.0m)(359.6m)(358.4m)(353.7m)(346.6m)(336.8m)

Total Equity

50.0m21.0m885.0k1.1m152.5m149.7m145.9m123.0m121.6m129.2m128.1m131.4m130.5m241.1m251.3m261.4m278.4m

Financial Leverage

3.1 x5.8 x97.4 x74.5 x1.4 x1.5 x1.5 x1.7 x1.7 x1.6 x1.6 x1.6 x1.6 x1.3 x1.2 x1.2 x1.3 x

Vanda Pharmaceuticals Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(20.3m)20.2m(39.9m)(18.0m)(15.6m)25.2m

Depreciation and Amortization

582.0k935.0k1.2m1.4m

Accounts Receivable

(863.0k)(1.6m)(12.7m)(4.3m)2.5m(11.2m)

Inventories

1.3m3.0m387.0k200.0k(1.1m)70.0k

Accounts Payable

374.0k174.0k9.4m575.0k6.0m(618.0k)

Cash From Operating Activities

(39.6m)(81.6m)12.4m(8.1m)(2.0m)30.0m

Purchases of PP&E

(176.0k)(769.0k)(2.5m)(1.4m)(1.7m)(368.0k)

Cash From Investing Activities

(34.3m)(12.0m)(26.6m)(10.1m)(10.1m)(109.7m)

Cash From Financing Activities

49.9m89.7m4.1m7.8m5.3m107.1m

Vanda Pharmaceuticals Ratios

USDY, 2019

Financial Leverage

1.3 x

Vanda Pharmaceuticals Employee Rating

2.012 votes
Culture & Values
1.4
Work/Life Balance
2.1
Senior Management
1.4
Salary & Benefits
2.4
Career Opportunities
1.6
Source